Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)
Clinical trial NCT03557333 · COMPLETED
Trial details
- NCT number
- NCT03557333
- Sponsor
- Impel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-13
- Primary completion
- 2020-03-17
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.